Introduction
The double-stranded (ds) RNA-activated serine/threonine protein kinase PKR (for protein kinase RNAdependent) is an interferon (IFN) inducible protein and a mediator of the anti-viral and anti-proliferative actions of IFN (Stark et al., 1998) . PKR, a 68 and 65 kDa protein in humans and mice respectively, is activated by autophosphorylation upon binding to dsRNA (Clemens and Elia, 1997) . Activated PKR then catalyzes the phosphorylation of the a-subunit of eukaryotic translation initiation factor 2 (eIF2a) on serine 51, a modi®cation that results in the inhibition of protein synthesis (Hershey, 1991) . PKR exhibits anti-viral (Katze, 1995; Yang et al., 1995; Balachandran et al., 2000; Stojdl et al., 2000) , anti-proliferative (Chong et al., 1992; Koromilas et al., 1992) and tumor suppressor functions in vitro (Koromilas et al., 1992; Meurs et al., 1993; Barber et al., 1995; Romano et al., 1998) . Consistent with an anti-proliferative action, activation of PKR in some cell systems can lead to the induction of cell death by apoptosis (Clemens and Elia, 1997; Balachandran et al., 1998; Srivastava et al., 1998) .
The molecular mechanisms by which PKR controls cell growth are still under investigation. In yeast, the mechanism of inhibition by PKR has been attributed to the decrease in protein synthesis mediated by the phosphorylation of the yeast eIF2a homologue, SU12 (Chong et al., 1992; Dever et al., 1992 Dever et al., , 1993 . In mammalian cells, the mechanisms of cell growth suppression by PKR are not yet elucidated. One possibility is the regulation of RNA translation through the modulation of eIF-2a phosphorylation. Consistent with this notion, expression of a mutant form of eIF2a with a substitution of serine 51 to alanine (eIF2aS51A), which cannot be phosphorylated by PKR, leads to malignant transformation of NIH3T3 cells and tumor formation after injection of transformed cells in nude mice (Donze et al., 1995) . A second possibility is the ability of PKR to participate in cell signaling leading to gene transcription in response to a variety of stimuli including dsRNA (Stark et al., 1998) , various cytokines (Stark et al., 1998) or genotoxic stress (Cuddihy et al., 1999a,b) .
The transcription factor NF-kB plays a critical role in a number of cellular functions, including proliferation, transformation, in¯ammatory and immune responses (Baldwin, 1996; Luque and Gelinas, 1997; Mosialos, 1997) . NF-kB is composed of dimers of dierent members of the Re1 protein family (Baldwin, 1996) . The most classical form of NF-kB is a heterodimer of p50 and p65 (RelA) , that is sequestered in the cytosol by the IkB proteins, which inhibit NFkB nuclear translocation and DNA-binding activity (Verma et al., 1995) . In response to various stimuli, IkBa bound to NF-kB is ubiquitinated on amino acid residues lysines 21 and 22 after phosphorylation on serines 32 and 36 by the IkB kinase (IKK) complex (Karin and Delhase, 1998) . Subsequently, IkBa is targeted for proteasome dependent degradation allowing the NF-kB complex to freely localize to the nucleus (Verma et al., 1995) , where it binds to DNA and induces transcription.
Early studies showed that PKR could phosphorylate IkBa and induce NF-kB DNA-binding in vitro although evidence for a direct phosphorylation of IkBa by PKR in vivo still remains elusive. Subsequent studies also showed that ablation of PKR by antisense mRNA (Maran et al., 1994) or depletion of the pkr gene by homologous recombination renders cells de®cient in NF-kB activation by dsRNA (Yang et al., 1995) thus providing a link between PKR and IkBa phosphorylation in vivo. Recent ®ndings have further proposed that PKR acts upstream to IKK (Bonnet et al., 2000; Gil et al., 2000; Zamanian-Daryoush et al., 2000) and NF-kB inducing kinase NIK (ZamanianDaryoush et al., 2000) . Also, modulation of IKK activity by PKR appears to be mediated by the recruitment of PKR in the IKK complex (Bonnet et al., 2000; Gil et al., 2000; Zamanian-Daryoush et al., 2000) .
We previously showed that mutants of PKR enhance HIV-1 replication in Jurkat T cells by inducing NF-kBdependent activation of HIV-1 gene transcription (Nagai et al., 1997) . To further understand the molecular function of PKR in NF-kB activation we have investigated the role of PKR mutants in IKK activation and IkBa phosphorylation. To this end, we used NIH3T3 cells stably expressing either the dsRNAbinding defective mutants PKRLS4 (arginine-58/serine-59/lysine-60 to glycine-58/alanine-59/leucine-60; Green and Mathews, 1992) and PKRLS9 (alanine-66/alanine-68 to glycine-66/proline-68; Green and Mathews, 1992) , or the catalytically inactive mutant PKRD6 (deletion of leu-phe-ile-gln-met-glu, residues 361 ± 366 in human PKR; Koromilas et al., 1992) . Here we report that expression of these PKR mutants is associated with enhanced basal levels of NF-kB DNA-binding and transactivation activities compared to control NIH3T3 cells. We show that phosphorylation of IkBa on serine 32 is induced in NIH3T3 cells expressing the PKR mutants, and this correlates with an increase in IKK activity. Furthermore, we demonstrate that the expression of a dominant negative IKK2 mutant (i.e. IKK2 K44A) in PKR mutant cells diminishes NF-kB-mediated transactivation. We also provide evidence that these eects are not due to transformed phenotype by the expression of mutants of PKR since NIH3T3 cells transformed either by the ras oncogene (Stacey and Kung, 1984) or the eIF2aS51A mutant (Donze et al., 1995) do not induce IKK activity. Also, in several NIH3T3 clones expressing variable amounts of PKRD6 or PKRLS9, the basal levels of NF-kB activation are enhanced in a dose dependent manner. Finally, NF-kB-dependent gene transactivation is induced by the PKR mutants when transiently transfected in NIH3T3 cells.
Results

Generation and characterization of NIH3T3 cells expressing mutants of human PKR
NIH3T3 cells expressing either the catalytic inactive PKRD6 (deletion of leu-phe-ile-gln-met-glu, residues 361 ± 366 in human PKR; Koromilas et al., 1992) or the dsRNA-binding defective PKRLS4 (arginine-58/serine-59/lysine-60 to glycine-58/alanine-59/leucine-60; Green and Mathews, 1992) were established by transfection and selection for neomycin-resistant cells as previously described . Generation of NIH3T3 cells stably expressing wild type (wt) human PKR was not possible due to the cell growth inhibitory properties of wt PKR (Koromilas et al., 1992) . Expression of PKR mutants was examined by immunoblot analysis (Figure 1 ) with a mouse monoclonal antibody (E8) that speci®cally recognizes the human PKR within the Cterminus half of the molecule (Nagai et al., 1997) . NIH3T3 cells expressing the amount of PKR mutants shown in Figure 1 (lanes 2 and 3) were used for further analysis and compared to neomycin-resistant NIH3T3 cells (control cells; lane 1).
Enhanced NF-kB DNA-binding in NIH3T3 cells expressing mutants of PKR The role of PKR mutants in NF-kB DNA-binding in NIH3T3 cell lines was examined by electrophoretic mobility shift assays (EMSAs) (Figure 2A ). Nuclear extracts from control cells (lanes 1 ± 5) and cells expressing either PKRD6 (lanes 6 ± 10) or PKRLS4 (lanes 11 ± 15) prepared before (lanes 1, 6, 11) or after TNF-a treatment for 1 h (lanes 2, 7, 12), 3 h (lanes 3, Figure 1 Expression levels of PKRD6 and PKRLS4 in NIH3T3 cells. Immunoblot analysis of PKR mutants. Protein extracts (50 mg) from control NIH3T3 cells (lane 1) and cells expressing PKRD6 (lane 2) or PKRLS4 (lane 3) were subjected to Western blotting ®rst with a mouse monoclonal antibody speci®c to human PKR (clone E8; top panel) and then with a mouse monoclonal anti-actin antibody (bottom panel) 8, 13) and 5 h (lanes 4, 9, 14) were subjected to EMSA using a 32 P-labeled double-stranded (ds) DNA oligonucleotide encompassing the two NF-kB sites from the human immunode®ciency virus (HIV)-1 enhancer (Lee et al., 1997) . In control cells, low levels of kB DNAbinding was detected in the absence of stimulation 5) , PKRD6 (lanes 6 ± 10) or PKR LS4 expressing cells (lanes 11 ± 15) before (lanes 1, 6 and 11) or after treatment with 10 ng/ml of human TNF-a for 1 h (lanes 2, 7 and 12), 3 h (lanes 3, 8 and 13) and 5 h (lanes 4, 9 and 14) were analysed for binding to 32 P-labeled HIV enhancer dsDNA oligonucleotide by EMSA. For cold competition DNA-binding reactions with nuclear extracts from cells stimulated with TNF-a for 5 h were incubated with a 200-fold excess of unlabeled HIV enhancer oligonucleotide (lanes 5, 10 and 15). (B) Analysis of NF-kB subunit composition by antibody supershift assays. Nuclear extracts (5 mg of protein) from untreated control cells (lanes 1 ± 4) and untreated PKRD6 (lanes 5 ± 8) or PKRLS4 expressing cells (lanes 9 ± 12) were incubated with 4 mg of speci®c antibodies to p65 (lanes 2, 6 and 10), p50 (lanes 3, 7 and 11), or cRel (lanes 4, 8 and 12) and tested for binding to Figure 2A , lanes 6 ± 9) and resulted in a moderate induction of complexes A, B and C in PKRLS4 cells (lanes 11 ± 14) . The speci®city of all complexes for binding to kB sequence was veri®ed by competition assays with an excess of unlabeled HIV enhancer dsDNA oligonucleotide (lanes 5, 10 and 15). Similar binding patterns were obtained when a dsDNA oligonucleotide encompassing the kB site from the human IkBa gene promoter was used (data not shown).
The identity of the kB complexes in unstimulated cells was ascertained by supershift assays using antibodies to the p65 (Campbell et al., 2000) , p50 (Campbell et al., 2000) or c-Rel (Segev et al., 2000) components of NF-kB ( Figure 2B ). Complex A (lane 9) was shifted with anti-p65 (lane 10) and anti-c-Rel antibodies (lane 12) and therefore is identi®ed as p65/ cRel heterodimer. Complex B (lanes 5 and 9) was shifted with anti-p65 (lanes 6 and 10) and anti-p50 antibodies (lanes 7 and 11) and therefore it consists of p50/p65 heterodimer. Formation of complex C (lanes 5 and 9) was abolished with anti-p50 antibodies only (lanes 7 and 11) and it most likely represents p50 homodimers. Complex D in PKRD6 expressing cells (lane 5) was partially diminished with anti-p65 (lane 6) and anti-p50 antibodies (lane 7). However, it is unlikely that complex D consists of p50/p65 heterodimer since complex B, which contains the p50/p65 heterodimer migrates slower than complex D. Based on this, it is possible that complex D contains two overlapping complexes each of them consisting of p50 or p65 in heterodimer form with an unknown protein(s). Alternatively, complex D may be the result of partial degradation of p50 and/or p65 subunits in PKRD6 but not in PKRLS4 nuclear cell extracts.
It is noteworthy that the dierences in the formation of NF-kB/DNA complexes between PKRD6 and PKRLS4 expressing cells may be indicative of distinct and complex regulatory pathways that lead to NF-kB activation and involves the PKR mutants. Such temporal and stimuli-dependent changes in NF-kB DNA binding have been reported previously (Garoufalis et al., 1994; Miyamoto et al., 1994) .
NF-kB-dependent gene transactivation is constitutively induced in NIH3T3 cells expressing mutants of PKR
To examine whether the dierences in DNA-binding have an eect on transcription, we next assessed NFkB-dependent transactivation in PKR mutant cells 
Enhanced phosphorylation of IkBa on serine 32 in NIH3T3 cells expressing mutants of PKR
To determine the cause of NF-kB activation, we then examined whether and how IkBa phosphorylation is regulated in PKR mutant cells (Figure 4 ). Protein extracts from untreated (lanes 1, 5 and 9) or TNF-atreated cells for 5 min (lanes 2, 6 and 10), 15 min (lanes 3, 7 and 11) and 30 min (lanes 4, 8 and 12) were subjected to immunoblot analysis with anti-phosphoserine 32 IkBa speci®c antibodies (top row). The protein levels of IkBa were measured by blotting the same membrane with anti-IkBa antibodies (middle row) and normalized to actin levels (bottom row). Phosphorylation of serine 32 of IkBa was induced in all cells after TNF-a treatment for 5 min (top panel, lanes 2, 6 and 10). However, serine 32 phosphorylation was diminished after 15 min (lanes 3, 7 and 11) and 30 min (lanes 4, 8 and 12) of stimulation due to downregulation of IkBa protein (middle panel) by degradation, which was prevented when cells were pretreated with with proteasome inhibitors prior to TNF-a stimulation (data not shown). We also noticed that the levels of IkBa phosphorylation on serine 32 were higher in unstimulated PKRD6 (lane 5) and PKRLS4 cells (lane 9) compared to control cells (lane (Figures 2 and 3) . Furthermore, we observed that IkBa protein was upregulated by the PKR mutants (middle panel, compare lanes 1 with 5 and 9, lane 2 with 6 and 10). The increase in IkBa levels was transcriptional in nature as judged by Northern blot analysis (data not shown). Since transcriptional activation of IkBa gene is dependent on NF-kB (Le Bail et al., 1993) , upregulation of IkBa RNA can be attributed to the higher levels of NF-kB activity in PKR mutant cells. Unlike IkBa, the expression IkBb was not aected by the mutants of PKR (data not shown). Quanti®cation of IkBa phosphorylation normalized to IkBa protein levels revealed an *3-and *2-fold induction of serine 32 phosphorylation in the unstimulated mutant PKRD6 and PKRLS4 cells, respectively (compare lane 1 with 5 and 9).
Enhanced IKK activity in NIH3T3 cells expressing the PKR mutants
Phosphorylation of IkBa on serines 32 and 36 is mediated by a large 700 ± 900 kDa complex with IkB kinase (IKK) activity (Karin and Delhase, 1998) . IKK1 and IKK2 are components of the IKK complex, whose activity is potently stimulated by TNF-a and interleukin (IL)-1 (DiDonato et al., 1997; Mercurio et al., 1997; Zandi et al., 1997) . The higher levels of IkBa phosphorylation on serine 32 in PKR mutant cells prompted us to determine whether IKK activity was implicated in this process ( Figure 5 ). First, IKK activation was measured in a pilot assay in control NIH3T3 cells before and after TNF-a stimulation ( Figure 5A ). Protein extracts were immunoprecipitated with an anti-IKK1 antibody and incubated with a GST-fusion protein containing the ®rst 55 amino acids of either wt human IkBa or a serine 32 and 36 to alanine double mutant of IkBa (IkBa MUT) in the presence of [ 32 P-g]ATP (DiDonato et al., 1997). In these assays, the lack of any background phosphorylation of GST-IkBa MUT before (lane 2) or after stimulation with TNF-a (lane 4) demonstrated the speci®city of IKK imuunoprecipitates for IkBa phosphorylation on serines 32 and 36. Next, we examined IKK activation levels in PKR mutant cells (Figure 5b ). In the absence of TNF-a stimulation, phosphorylation of GST-IkBa by IKK ( Figure 5B , middle row) was more highly induced in the extracts from PKRD6 (lane 4) and PKRLS4 cells (lane 7) compared to control cells (lane 1). Quanti®cation of GST-IkBa phosphorylation (middle row) after normalization to GST-IkBa protein levels (bottom row) showed about 10-fold and ®vefold higher phosphorylation for PKRD6 and PKRLS4 cells respectively, compared to control cells. Stimulation with TNF-a resulted in 5 ± 10-fold induction of IKK activity in control cells (lanes 2 and 3) but in a moderate 1.5 ± 2-fold induction in cells expressing PKRD6 (lanes 5 and 6) or PKRLS4 (lanes 8 and 9). This modest induction by TNF-a is likely to be due to the high basal levels of IKK activity in PKR mutant cells. These dierences in IKK activity were not due to variations in IKK levels since immunoblot analysis showed that an equal amount of IKK1 was present in all reactions (top row). In contrast to IKK, activation of p90 rsk , which has been shown to directly phosphorylate IkBa on serine 32 in vitro (Ghoda et al., 1997; Schouten et al., 1997) , was not modulated by the PKR mutants (data not shown).
Inhibition of NF-kB-mediated transactivation in cells expressing mutants of PKR by a dominant negative mutant of IKK2
The enhanced IKK activation of PKR mutant cells was further veri®ed by the expression of the dominant negative IKK2 K44A mutant (Mercurio et al., 1997) . To this end, cells were transfected with the luciferase reporter gene under the control of HIV-1 enhancer and increasing amounts of IKK2 K44A DNA (Figure 6 ). Transfection with the IKK2 K44A resulted in a dosedependent inhibition of NF-kB transactivation in both PKRD6 ( Figure 6A ) and PKRLS4 cells ( Figure 6B ) suggesting that the eects of the PKR mutants are exerted at the IKK level.
Transformed NIH3T3 cells do not display enhanced IKK activity
Stable expression of mutants of PKR in NIH3T3 cells is associated with transformation and tumorigenesis (Koromilas et al., 1992; Meurs et al., 1993; Barber et al., 1995; Romano et al., 1998) . This prompted us to examine whether enhanced IKK activation is elicited by the transformed phenotype of the NIH3T3 cells rather than by the function of PKR mutants per se. To this end, NIH3T3 cells transformed either by the eIF2aS51A mutant (Donze et al., 1995) or the RAS oncoprotein (Stacey and Kung, 1984) were subjected to IKK kinase assay ( Figure 7A,B) . These experiments revealed no signi®cant dierences in the basal IKK activity levels before and after TNF-a treatment in either EIF2aS51A ( Figure 7A , compare lanes 1 and 3) or RAS transformed NIH3T3 cells compared to nontransformed NIH3T3 cells ( Figure 7B , compare lanes 1 and 3). Therefore, these data suggest that enhanced IKK activity is not necessarily a property of NIH3T3 transformation.
NIH3T3 cells expressing mutants of PKR display equal levels of JNK-1 activation
Recent studies by Osman et al. (1999) have demonstrated that PKR regulates TNF-a expression by modulating TNF-a mRNA splicing. TNF-a is an inducer of both IKK and Jun-N-terminal kinase (JNK/SAPK) leading to the activation of transcription factor NF-kB and AP-1 respectively (Derijard et al., ± 3) , PKRD6 (lanes 4 ± 6) and PKR LS4 cells (lanes 7 ± 9) before (lanes 1, 4 and 7) or after treatment with 10 ng/ml of human TNF-a for 5 min (lanes 2, 5, 8) and 15 min (lanes 3, 6, 9) were immunoprecipitated with anti-IKK1 antibody (sc-7218). IKK immunoprecipitates were then used for in vitro kinase assays (KA) in the presence of a GST-IkBa protein and [g-32 P]ATP. At the end of incubation, half of the reaction was subjected to SDS ± 10%PAGE and Western blot analysis with anti-IKK1 antibody (WB, top row) whereas the other half to SDS ± 10%PAGE, staining with Coomassie Blue (CB, bottom row) and autoradiography (KA, middle row). Fold phosphorylation for each sample represents the ratio of GST-IkBa phosphorylation (middle row) to GST-IkBa protein level (bottom row) 1994; Kyriakis et al., 1994; Reinhard et al., 1997) . To examine whether the elevated levels of IKK activity might have been caused by an increase in TNF-a production in PKR mutant cells, we measured JNK-1 activity by Western blotting using a phosphospeci®c antibody against the activated JNK-1 (Figure 8 ). In these assays we measured equal levels of JNK-1 activity in both PKR mutant and control NIH3T3 cells (Figure 8, lanes 1, 3 and 5 ). These data show that upregulation of IKK activity in PKR mutant cells is unlikely to be caused by the production of TNF-a or any other ligand that functions through the TNF receptor family of proteins.
Constitutive NF-kB binding in NIH3T3 clones stably expressing variable levels of the PKR mutants
To diminish the possibility of clonal eects of PKR mutant cells on IKK activation, we established NIH3T3 cell lines expressing variable levels of PKR mutants by retroviral transduction. Cells expressing increasing amounts of either PKRD6 ( Figure 9A , lanes 2 ± 4) or the dsRNA-binding defective mutant PKRLS9
(alanine-66/alanine-68 to glycine-66/proline-68; Green and Mathews, 1992) ( Figure 9A , lanes 5 ± 7) were tested for NF-kB DNA-binding with the HIV enhancer probe ( Figure 9B ). These clones were compared to the control polyclonal population of puromycin resistant NIH3T3 cells containing the pBABE vector. We observed that expression of either PKR mutant results in an increase in NF-kB DNA-binding, which correlates with the amount of PKR mutant protein within the cells. We also noticed that the DNA-binding pattern of NF-kB varies when dierent extraction methods are used. For example, the complex pattern of NF-kB DNA-binding observed with nuclear extracts from PKR mutant cells (Figure 2) is simpli®ed when whole cell extracts are used ( Figure 9B ). Nevertheless, both methods demonstrate the enhanced levels of NFkB DNA-binding activity by the mutants of PKR. The upregulation of NF-kB DNA-binding in various PKR mutant expressing cells argues against clonal variation eects and shows clearly that the induction of NF-kB activity is dependent upon the amount of PKR mutant proteins expressed in the NIH3T3 cells.
Enhanced NF-kB-dependent transactivation by wild type and mutants of human PKR transiently expressed in NIH3T3 cells
To further eliminate the possibility of clonal variations and to verify the kinase-and RNA-binding-independent functions of PKR, we performed transient transfections of wt human PKR or mutant PKR cDNAs in the presence of luciferase reporter gene under the control of HIV-1 kB enhancer (Figure 10) . Expression of wtPKR, PKRD6 or PKRLS9 resulted in a 1.6-, 1.4-and 2.2-fold stimulation of NF-kB-dependent transactivation respectively (Figure 10 ). The expression levels of transiently transfected PKR mutants were detected by immunoblot analysis with a mouse monoclonal anti-human PKR speci®c antibody, which shows no cross-reactivity with the endogenous mouse PKR (Figure 10, right top panel) . The modest but reproducible enhanced transactivation levels of NF-kB by the PKR mutants are most likely due to the nature of NIH3T3 cells to respond weakly to transient NF-kB-dependent transactivation assays (Demarchi et al., 1999; Bonnet et al., 2000) . [Note the modest threefold induction of HIV-1 enhancer-driven luciferase activity after TNF-a stimulation (positive control)]. Similar levels of NF-kB-dependent HIV-1-driven gene transactivation were also observed by Bonnet et al. (2000) in mouse ®broblasts transiently transfected with wt human PKR or catalytic mutants of human PKR. These data together verify the ability of PKR to induce NF-kB activation in a manner that is independent of the enzymatic and dsRNA-binding properties of the molecule.
Discussion
In this study we demonstrate that induction of IKK and NF-kB by PKR proceeds independently of the 6 and 10). We also show that induction of NF-kB activity by the PKR mutants is due to increased IKK activation ( Figure 5 ) and IkBa phosphorylation on serine 32 in vivo ( Figure  4 ). This is further supported by the observation that expression of the dominant negative IKK2 and K44A mutant diminishes NF-kB-mediated transactivation in PKR mutant cells (Figure 6 ). The increased IKK activity, however, is unlikely to derive from an autocrine or paracrine action of cytokines that trigger TNF type I receptor signaling, since JNK activity is normal in NIH3T3 PKR mutant cells (Figure 8 ).
Considering the transforming capacity of PKR mutants and the positive eect of NF-kB on cell growth we initially speculated that the induction of NF-kB might be a secondary eect elicited from the tranformed phenotype of the PKR mutant cells. However, this possibility is diminished by the observation that NIH3T3 cells transformed by activated RAS or the eIF2aS51A mutant do not exhibit elevated levels of IKK activity (Figure 7 ). In addition, the constitutive induction of NF-kB is not a clonal eect of the PKR mutant cells since: (i) NF-kB DNA-binding activity is induced in several NIH3T3 clones stably expressing the PKR mutants ( Figure 9B) ; and (ii) NF-kB-mediated transactivation is induced by the PKR mutants in transient transfection assays (Figure 10) . Signi®cantly, induction of NF-kB activity is dependent on the amount of the PKR mutant proteins expressed in NIH3T3 cells (Figure 9) .
Activation of NF-kB by dsRNA requires the presence of PKR (Chu et al., 1999; Gil et al., 2000; Zamanian-Daryoush et al., 2000) . Speci®cally, it has been shown that the DNA-binding and transactivation (lanes 1, 2), PKRD6 (lanes 3, 4) , and PKR LS4 cells (lanes 5, 6) were treated with TNF-a for 15 min (lanes 2, 4 and 6). Protein extracts were subjected to immunoblot with antiphospho-JNK antibody (upper panel). Subsequently the blot was stripped o and re-probed with anti-JNK antibody (lower panel) Figure 9 Induction of NF-kB in NIH3T3 cells is dependent on the amount of PKR mutants. Whole cell extracts (50 mg of total protein) from NIH3T3 cells isolated after infection with either pBABE control retrovirus (pBABE control, lane 1) or pBABE retrovirus transducing PKRD6 (pBABE-PKRD6; clones 12, 10 and 11 in lanes 2, 3, 4 respectively), or pBABE retrovirus bearing PKRLS9 (pBABE-PKRLS9; clones 4, 3, 2 in lanes 5, 6, 7 respectively) were subjected to immunoblot analysis ®rst with a rabbit antihuman PKR speci®c polyclonal antibody (A, top panel) followed by immunoblotting for b-actin levels (A, bottom panel). NS, nonspeci®c band above the human PKR protein that is also detected in control cells (lane 1). The same extracts (10 mg of total protein) were subjected to EMSA for NF-kB DNA-binding using the HIV enhancer probe (B). As positive control for EMSA, NIH3T3 pBABE control cell extracts after treatment with TNF-a (10 ng/ml) for 10 min were used (B, lane 8). The speci®city to NF-kB DNAbinding is shown by the cold competition with unlabeled probe (200-fold excess; lane 9) using the TNF-a treated extracts of lane 8 the properties of PKR (i.e. catalytic and/or dsRNAbinding) that are implicated in this process have not as yet been characterized. In the absence of dsRNA treatment, however, we (this study) and other (Chu et al., 1999; Bonnet et al., 2000) favor an enzymatic-free function of PKR. Using dierent PKR catalytic mutants, our and Meurs' groups (Bonnet et al., 2000) reached the conclusion that the enzymatic activity of PKR is dispensable for IKK and NF-kB activation. Consistent with this, Chu et al. (1999) showed the induction of IKK activity by both recombinant wt PKR and PKRK296R mutant in vitro. In addition to catalytic mutants, we clearly demonstrate that IKK activation does not require the dsRNA-binding function of PKR either. Taken together, these data provide strong evidence that the signaling and translational functions of PKR may be separate. That is, PKRmediated signaling may require the kinase to act as a scaold protein through protein-protein interactions with other signaling molecules as has been established for the IKK complex (Zamanian-Daryoush et al., 2000; Gil et al., 2000; Bonnet et al., 2000) and the transcription factor Stat1 (Wong et al., , 2001 ). On the other hand, the translational function of PKR is dependent on both the RNA-binding and catalytic properties of the kinase (Clemens and Elia, 1997) . In regard to IKK activation, conformational changes of PKR might aect the strength and/or speci®city of the interaction with the IKK complex leading to dierential NF-kB transactivation levels elicited by various stimuli. Interestingly, conformational changes and proper folding have been proposed to be important for the biochemical and biological functions of PKR (Sharp et al., 1998) . Such conformational alterations might also be induced by various mutations in PKR protein, and this could explain the dierences in the pattern of NF-kB DNA-binding ( Figure 2 ) and transactivation (Figures 3, 6 and 10) between the PKRD6 and PKRLS4 expressing cells. In analogy to PKR, a kinase-free function of a component of the NF-kB activation pathways has already been demonstrated for the RIP kinase, which activates NF-kB through its association with TRAF2 (Hsu et al., 1996; Ting et al., 1996; Kelliher et al., 1998) .
Considering the physiological relevance of our ®ndings, activation of NF-kB may be another mechanism, in addition to the inhibition of eIF-2a phosphorylation (Donze et al., 1995) , utilized by the mutants of PKR to transform cells in culture (Koromilas et al., 1992 Meurs et al., 1993 Barber et al., 1995 Romano et al., 1998) . In analogy to PKR mutants, inhibition of IkBa expression by antisense RNA leads to constitutive NF-kB activation, which is associated with cell transformation and tumor formation in nude mice (Beauparlant et al., 1994) . Also, activation of NF-kB may play a role in the anti-apoptotic function of PKR mutants (Balachandran et al., 1998; Srivastava et al., 1998) . For example, activation of PKR and phosphorylation of eIF-2a have been shown to mediate the apoptotic cell death induced by dsRNA (Balachandran et al., 1998) or TNF-a (Srivastava et al., 1998) possibly through the translational inhibition of anti-apoptotic genes. Based on these and our data, it is reasonable to speculate that mutants of PKR can facilitate the expression of anti-apoptotic genes both at the tran- To decrease basal NF-kB activity, transfection and treatment was performed in 0.5% calf serum (Demarchi et al., 1999) . NIH3T3 cells (2610 4 ) were co-transfected with 50 ng of wild type HIV-1 enhancer/luciferase vector, 10 ng of renilla luciferase in pRL-TK vector (internal control) and 350 ng of pEF vector containing either human wt PKR, PKRD6 or PKRLS9 cDNA. Cell extracts were prepared 24 h after transfection and analysed for luciferase activity. As control NIH3T3 cells were co-transfected with 50 ng of either wild type or a kB mutant HIV-1 enhancer/luciferase construct, 10 ng of renilla luciferase in pRL-TK vector (internal control) and 350 ng of empty pEF vector. Cells were grown for 12 h, stimulated with 10 ng/ml of TNF-a for an additional 12 h before measuring luciferase activity. Each transfection was performed in triplicates and values represent the average of four separate experiments scriptional and translational levels by mediating NF-kB activation and suppressing eIF-2a phosphorylation respectively.
Activation of NF-kB, however, may play a dual role in the cell growth control by PKR. That is, Gil et al. (1999) have shown that eIF-2a phosphorylation and NF-kB activation are both involved in apoptosis induced by the overexpression of wtPKR. It seems then, that modulation of eIF-2a phosphorylation by PKR can determine whether NF-kB activation has a positive or negative eect on cell proliferation. That is, upon conditions that eIF-2a phosphorylation is blocked (i.e. expression of PKR mutants or PKR inhibitors) activation of NF-kB may induce cell proliferation (our study and Bonnet et al., 2000) whereras induction of eIF-2a phosphorylation and NF-kB activation by PKR upon viral infection, dsRNA or TNF-a may lead to suppression of cell growth and/or induction of apoptosis Balachandran et al., 1998; Srivastava et al., 1998; Gil et al., 1999) . Thus, the kinase and RNA-binding activities of PKR may not be important for NF-kB activation but are essential for the PKR-mediated control of cell growth through the modulation of eIF-2a phosphorylation and cellular protein synthesis.
Materials and methods
Plasmid constructions
The luciferase reporter gene under the control of the wild type HIV-1 enhancer or a mutant form of the HIV-1 enhancer with mutations in the NF-kB binding sites was constructed as follows: Wild type HIV enhancer/CAT and mutant HIV enhancer/CAT plasmids (Kwon et al., 1998) were digested with AccI and HindIII and the HindIII/AccI (blunt end) fragment, which contains the HIV enhancer and the minimal SV40 promoter, was introduced into HindIII/ SmaI sites of pGL3 vector (Promega). pBABE PKRD6 and pBABE PKRLS9 were generated by subcloning PKRD6 and PKRLS9 cDNAs with the BamHI site of pBABE vector (Morgenstern and Land, 1990) .
GST-IkBa fusion proteins encompassing the ®rst 55 amino acids of IkBa was constructed by PCR ampli®cation of the human wild type (wt) IkBa cDNA or serine 32,36 to alanine mutant of human IkBa in the pGEX-2T vector by the following set of primers: 5'-d[GGGCTGGCAAGCCACGTT-TGGTG]-3' and 5'-d[GGGGGGAATTCCTACTCGAGGC-GGATCTCCTGC]-3' (Sheldon Biotechnology Center, Montreal, Canada). The ampli®ed cDNA fragment was digested with EcoRI and clones into the EcoRI site of the pGEX-2T vector.
Wild type human PKR, PKRD6 and PKRLS9 cDNAs were subcloned in ClaI/BamHI sites of pEF vector (Mizushima and Nagata, 1990) , which drives transcription under the control of human translation elongation factor-a gene promoter.
Cell culture and transfections
Cells expressing PKR mutants were generated by transfection of NIH3T3 cells (ATCC CRL-1658) with PKRD6 or PKRLS4 cDNA in pcDNA3.0/neo vector and selection in 400 mg/ml of G418 as previously described . NIH3T3
were grown in Dulbecco's modi®ed Eagle's medium (Life Technologies Inc.) Supplemented with 10% of heat-inactivated calf serum (CS; Life Technologies Inc.), penicillin (100 units/ ml; Life Technologies Inc). And streptomycin (100 units/ml; Life Technologies Inc). pBABE, pBABE-PKRD6 and pBABE-PKRLS9 NIH3T3 cells were generated as previously described (Morgenstern and Land, 1990) .
For transient transfections, NIH3T3 cells were seeded onto 24-well plates (2610 4 cells per well) and the following day were transfected with the lipofectamine-plus reagent according to the manufacturer's speci®cation (Gibco ± BRL). All transfections included Renilla luciferase DNA in the pRL-TK vector (Promega) as an internal control. Twenty-four to thirty hours after transfection, cells were harvested with 16 passive lysis buer (Promega) and luciferase activity was measured by the dual-luciferase reporter assay kit (Promega Inc.) In a Lumat LB 9507 luminometer (EG&G Berthold).
Western blot analysis
Cells were lysed in 16 mitogen-activated protein kinase (MAPK) lysis buer (Shifrin et al., 1997) in the presence of 3 mg/ml aprotinin, 1 mg/ml pepstatin, 1 mg/ml leupeptin, 2 mM dithiothreitol (DTT), and 1 mM phenylmethylsulfonyl uoride (PMSF). Extracts were kept on ice for 15 min, centrifuged at 10 000 g for 15 min (48C) and supernatants were stored at 7808C.
For Western blot analysis protein extracts (50 mg) were subjected to sodium dodecyl sulfate (SDS)-10% polyacrylamide gel electrophoresis (SDS ± PAGE) as described . Proteins were then electroblotted onto nylon membranes (Immobilon P, Millipore) which were incubated with any of the following antibodies: (i) mouse monoclonal antibody to human PKR (13B8-E8); (ii) immunopuri®ed rabbit antisera to IkBa (06-494), Upstate Biotechnology Inc); (iii) mouse monoclonal to actin (C4, ICA); (iv) immunopuri®ed rabbit antisera to phosphoserine 32 of IkBa (9214S, New England Biolabs); (v) immunopuri®ed rabbit antisera to IKK1 (SC-7218, Santa Cruz, CA, USA); (vi) immunopuri®ed rabbit antisera to JNK1 (SC-474, SantaCruz, CA, USA); (vii) immunopuri®ed rabbit antisera to anti-active JNK (v7931, Promega). Proteins were visualized by enhanced chemiluminescence according to manufacturer's speci®cation (Amersham Life Science Inc., Cleveland, OH, USA).
Preparation of nuclear extracts and electrophoretic mobility shift assays (EMSA)
For EMSAs, 5 mg of nuclear (Nagai et al., 1997) or whole cell extracts were incubated with 80 pg of a 5'-end 32 P-labeled HIV enhancer dsDNA oligonucleotide (5610 6 c.p.m./ng; 5'-AGGGACTTTCCGCTGGGACTTT-CC-3'; underscored sequences correspond to the NF-kB binding sites) and analysed on 6% polyacrylamide gels as previously described (Nagai et al., 1997) .
For super shift assays, immunopuri®ed rabbit polyclonal antibodies to p65 (SC-7151X, SantaCruz; Campbell et al., 2000) , anti-c-Rel mouse monoclonal antibody (SC6955X, SantaCruz; Campbell et al., 2000) or anti-p50 goat polyclonal antibody (SC-1190x, SantaCruz; Campbell et al., 2000) were incubated with nuclear extracts at room temperature for 20 min prior to EMSA.
IKK immunoprecipitations and in vitro kinase assays
IKK immunoprecipitations were performed as previously described (DiDonato et al., 1997) using immunopuri®ed After the end of the incubation the kinase reactions were subjected to SDS-10%PAGE and radioactive proteins were visualized by autoradiography.
